Methylphenidate for gait hypokinesia and freezing in patients with Parkinsons disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
La tirzepatida, un agonista dual GIP/GLP-1, ha demostrado reducciones an mayores (15-21% en el estudio SURMOUNT-1)
Skin irritation from herbal patches can occur, and maintaining skin integrity during use is important
Secondary analysis of renal end points in a cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM at high cardiovascular risk, showing that saxagliptin reduces albuminuria in a glucose-independent manner
Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al
Second, without a pre-treatment measurement, there is no way to distinguish a medication-related change in your labs from a change that was already present before you started